期刊文献+

血浆脑钠肽结合超声心动图对心脏病患者心功能的评估 被引量:20

Clinical practical research on plasma brain natriuretic peptide and ultrasoundcardiogram to evaluate the patients with heart failure
原文传递
导出
摘要 目的:探讨血浆脑钠肽(BNP)值结合超声心动图(UCG)相关参数对心脏病患者心功能的评估价值。方法:测定147例住院心脏病患者血浆BNP值,同时测定UCG各相关参数。分析患者静息心率、心功能分级、左室射血分数(LVEF)、二尖瓣口舒张早期与舒张晚期血流峰值速度比值(E/A值)、左室收缩末径(LVEDs)、左室舒张末径(LVEDd)、左房内径(LAD)、左室短轴缩短率(LVFS)等因素与BNP的相关性。结果:血浆BNP水平随NYHA心功能分级程度的升高而显著增加(r=0.645,P<0.001)。BNP与LVEF呈负相关(r=-0.451,P<0.001)。BNP与LVEDs、LVEDd的Pearson系数分别为0.473、0.401(P<0.01)。结论:BNP水平与NYHA心功能分级高度相关,可预测LVEF的下降,能较好地反映心脏病患者左室功能状态;BNP结合UCG相关参数,是一种无创、简便、敏感的评价心功能的方法。 Objective:The aim of this study was to evaluate the heart function by plasma brain natriuretic peptide (BNP) and ultrasoundcardiography (UCG), and further to evaluate the clinical value of BNP in diagnosis and illness evaluation of heart failure patients. Metbod: We measured the plasma BNP levels and UCG parameters of 147 patients with heart disease. Correlation analysis was made between plasma concentrations of BNP and LVEF, E/A, Hr, MAP, NYHA classification, LVEDs, LVEDd, LAD. Result: The plasma BNP level correlated positively with NYHA class (r= 0. 645,P〈0. 001)and negatively with LVEF(r= -0. 451, P〈0. 001). Pearson coefficients are 0. 473, 0. 401 between BNP and LVEDs, BNP and LVEDd, respectively (P〈0. 001). Conclusion.. The concentration of plasma BNP correlated with NYHA classification and the degree of LV systolic and diastolic dysfunctions evaluated by UCG. BNP measurement combined with UCG offer useful information regarding heart failure.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2008年第12期894-897,共4页 Journal of Clinical Cardiology
关键词 超声心动描记术 脑钠肽 心功能 Ultrasoundcardiography Brain natriuretic peptide Heart function
  • 相关文献

参考文献12

  • 1刘治全.高血压的临床评估//马爱群,胡大一,牛小麟.心血管病学-供研究生用[M].北京:人民卫生出版社,2005:366-374.
  • 2SHAPIRO B P, CHEN H H, BURNETT J C Jr, et al. Use of plasma brain natriuretic peptide concentration to aid in the diagnosis of heart failure[J]. Mayo Clin Proc, 2003, 78:481-486.
  • 3TSUCHIDA K, TANABE K. Influence of paroxysmal atrial fibrillation attack on brain natriuretic peptide secretion[J]. J Cardiol, 2004, 44:1-11.
  • 4SHADMAN R, ALLISON M A, CRIQUI M H. Glomerular filtration rate and n-terminal pro-brain natriuretic peptide as predictors of cardiovascular mortality in vascular patients[J]. J Am Coll Cardiol, 2007,49 : 2172-2181.
  • 5WOLFF B, HAASE D, LAZARUS P, et al. Severe septic inflammation as a strong stimulus of myocardial NT-pro brain natriuretic peptide release [J]. Int J Cardiol, 2007,122:131-136.
  • 6CLERICO A, EMDIN M. Diagnostic accuracy and prognostic relevance of the measurement of cardiac na triuretic peptides[J]. Clin Chem, 2004, 50 : 33- 50.
  • 7TSUTAMOTO T, WADA A, SAKAI H, et al. Re lationship between renal function and plasma brain na triuretic peptide in patients with heart failure [J].J Am Coll Cardiol, 2006, 47:582-586.
  • 8JANUZZI J L, VAN KIMMENADE R, LAINCHBURY J, et al. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients. The international collaborative of NT-proBNP study [J]. Eur Heart J, 2006,27:330-337.
  • 9胡咏梅,赵思勤,李秋,聂晓莉,吴涛,刘小蓉,王勉,张文勇.慢性心力衰竭患者血浆脑钠肽和内皮素-1水平与血流动力学的相关性[J].临床心血管病杂志,2006,22(11):672-674. 被引量:27
  • 10GROENNING B A, NILSSON J C, SONDERGAARD L, et al. Detection of left ventricular enlargement and impaired systolic function with plasma N-terminal pro-brain natriuretic peptide concentrations[J].Am Heart J, 2002, 143:923-929.

二级参考文献14

  • 1GROENNING B A, NILSSON J C, SONDERGAARD L, et al. Evaluation of impaired left ventricular ejection fraction and increased dimensions by multiple neurohumoral plasma concentrations [J].Eur J Heart Fail, 2001,3:699-708.
  • 2BARTON M, KIOWSKI W. The therapeutic potential of endothelin receptor antagonists in cardiovascular disease[J]. Curr Hypertens Rep, 2001,3:322- 330.
  • 3BOULANGER C M. Secondary endothelial dysfunction: hypertension and heart failure[J]. J Cell Cardiol, 1999,31: 39-49.
  • 4YAMAMOTO K, BURNETT J, BERMUDEZ E A, et al. Clinical criteria and biochemical markers for the detection of systolic dysfunction[J]. J Card Fail, 2000,6:194-200.
  • 5KAZANEGRA R, CHENG V, GARCIA A, et al. A rapid test for B-type natriuretic peptide correlates with falling wedge pressure in patients treated for decompensated heart failure: A pilot study[J]. J Card Fail, 2001,7:21-29.
  • 6MULDER P, BOUJEDAINI, H, RICHARD V, et al. Long-term survival and hemodynamics after endothelin-a receptor antagonism and angiotensin-converting enzyme inhibition in rats with chronic heart failure: monotherapy versus combination therapy [J]. Circulation, 2002,27,106: 1159-1164.
  • 7LUCHNER A, STEVENS TL, BORGESON DD, et al. Differential atrial and ventricular expression of myocardial BNP during evolution of heart failure[J]. Am J Physiol, 1998,274:1684-1689.
  • 8SUZUKI T, YAMAZAKI Y, YAZAKI Y. The role of the natriuretic peptide in the cardiovascular system [J]. Cardiovasc Res, 2001,51:489-494.
  • 9SAM F, COLUCCI WS. Role of endothelin-1 in myocardial failure[J]. Proc Assoc Am Physicians, 1999, 111: 417-422.
  • 10DUCHMAN S M, THOHAN V, KALRAD, et al. Endothelin-1: a new target of therapeutic intervention for the treatment of heart failure[J]. Curr Opin Cardiol, 2000,15:136-140.

共引文献43

同被引文献148

引证文献20

二级引证文献138

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部